H.C. Wainwright lowered the firm’s price target on Bionano Genomics (BNGO) to $7 from $11 and keeps a Buy rating on the shares. The firm adjusted the company’s model post the Q3 report. Claim 60% off ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results